In another composition aspect of the present invention, the aerosol comprises particles comprising at least 5 percent by weight of quinine, chlorzoxazone, carisoprodol or cyclobenzaprine.
the particles comprise at least 10 percent by weight of quinine, chlorzoxazone, carisoprodol or cyclobenzaprine.